WO1990001328A1 - Fnt et ses compositions dans le traitement ou la prophylaxie de l'hepatite b - Google Patents

Fnt et ses compositions dans le traitement ou la prophylaxie de l'hepatite b Download PDF

Info

Publication number
WO1990001328A1
WO1990001328A1 PCT/GB1989/000897 GB8900897W WO9001328A1 WO 1990001328 A1 WO1990001328 A1 WO 1990001328A1 GB 8900897 W GB8900897 W GB 8900897W WO 9001328 A1 WO9001328 A1 WO 9001328A1
Authority
WO
WIPO (PCT)
Prior art keywords
tnf
formulation
hepatitis
treatment
human
Prior art date
Application number
PCT/GB1989/000897
Other languages
English (en)
Inventor
Roger Samuel Williams
Graeme James Mackay Alexander
Christopher R. Franks
Original Assignee
Roger Samuel Williams
Graeme James Mackay Alexander
Franks Christopher R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roger Samuel Williams, Graeme James Mackay Alexander, Franks Christopher R filed Critical Roger Samuel Williams
Publication of WO1990001328A1 publication Critical patent/WO1990001328A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta

Abstract

Un médicament pour le traitement de l'hépatite B chez des mammifères comprenant le FNT (facteur de nécrose tumorale), ainsi que des procédés d'administration d'un tel médicament.
PCT/GB1989/000897 1988-08-04 1989-08-04 Fnt et ses compositions dans le traitement ou la prophylaxie de l'hepatite b WO1990001328A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8818567.3 1988-08-04
GB8818567A GB2221619A (en) 1988-08-04 1988-08-04 Tnf in the treatment of hepatitis b

Publications (1)

Publication Number Publication Date
WO1990001328A1 true WO1990001328A1 (fr) 1990-02-22

Family

ID=10641628

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1989/000897 WO1990001328A1 (fr) 1988-08-04 1989-08-04 Fnt et ses compositions dans le traitement ou la prophylaxie de l'hepatite b

Country Status (2)

Country Link
GB (1) GB2221619A (fr)
WO (1) WO1990001328A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5717741A (en) * 1992-08-26 1998-02-10 Bellsouth Corp. Method for handling telephonic messages

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525750A1 (de) * 1985-07-19 1987-01-29 Basf Ag Verwendung von tnp zur herstellung von arzneimitteln

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Baillieres Clin. Gastroenterol., Vol. 3, No. 1, January 1989 G. Alexander: "Treatment of Acute and Chronic Viral Hepatitis" pages 1-20 *
British Medical Journal, Vol. 292, No. 6525, 5 April 1986, British Medical Journal, (London, GB) G. ALEXANDER et al.: "Antiviral Treatment in Chronic Infection with Hepatitus B Virus", pages 915-917 *
Gastroenterology, Vol. 92 (5 Part 2) May 1987 R. HERRMANN et al.: "Normal Tumor Necrosis Factor in Alcoholic Hepatitis" page 1795 *
Hepatology, Vol. 8, No. 5, November 1988, F.LARRAS et al.: "Tumor Necrosis Factor in Chronic Hepatitus B", see Abstract 267 *
Medical Hypotheses, Vol. 27, No. 3, 1988 Longman Group UK Ltd (GB) D. ADERKA et al.: "Does Tumor Necrosis Factor Play a Role in the Pathogenesis of Fulminant Hepatitis? pages 193-196 *
Nature, Vol. 323, 30 October 1986, G.H.W. WONG et al.: "Tomour Necrosis Factors alpha and beta Inhibit Virus Replication and Synergize with Interferons", pages 819-822 *
The Lancet, Vol. 2, No. 8602, 9 July 1988 Y. MUTO et al.: "Enhanced Tumour Necrosis Factor and Interleukin-1 in Fulminant Hepatic Failure", pages 72-74 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5717741A (en) * 1992-08-26 1998-02-10 Bellsouth Corp. Method for handling telephonic messages
US5764747A (en) * 1992-08-26 1998-06-09 Bellsouth Corporation Personal number communication system
US5857013A (en) * 1992-08-26 1999-01-05 Bellsouth Corporation Method for automatically returning voice mail messages

Also Published As

Publication number Publication date
GB8818567D0 (en) 1988-09-07
GB2221619A (en) 1990-02-14

Similar Documents

Publication Publication Date Title
CA1290248C (fr) Traitement d'infections a l'aide de lymphochines
JP3246918B2 (ja) 感染症の治療のためのＩＬ―１２およびＩＦＮαの使用
US5128126A (en) Use of pharmaceutical compositions containing at least one cytokine for the systemic treatment of preneoplastic lesions
KR19990082084A (ko) 인터페론으로 선행치료한 hcv 환자를 재치료하기 위한 제약학적 조성물
JP2005029561A (ja) コンセンサスヒト白血球インターフェロンを含有する抗腫瘍剤
JP2003246750A (ja) 持続的低用量サイトカイン注入治療
JPH08510242A (ja) ガンマインターフェロンの安定液体組成物
Browder et al. The interferons and their use in condyloma acuminata
EP0225759B1 (fr) Compositions d'interféron
US5230886A (en) Tumor cell suppression
US6455051B1 (en) Ameliorant for hepatitis C therapeutic effect and application thereof
WO1988009673A1 (fr) Traitement de l'hepatite b de type chronique avec une combinaison d'interferons alpha et gamma humains recombinants
WO1990001328A1 (fr) Fnt et ses compositions dans le traitement ou la prophylaxie de l'hepatite b
JPS62215535A (ja) ウイルス感染の予防および治療用組成物
EP0589378A2 (fr) Cytokines glycosylées
WO2004022088A1 (fr) Hybride d'interféron et de fragment fc d'immunoglobuline
EP0956040B1 (fr) Stimulation des mecanismes de defense hotes contre des attaques virales
WO1989000805A2 (fr) Traitement d'infections avec un facteur de necrose des tumeurs
CA2600714A1 (fr) Methodes permettant de traiter ou de prevenir une maladie, un trouble ou un etat pathologique associes a une infection virale
EP0273778A2 (fr) Comportement synergique de csf-1 et G-csf
JP2000007578A (ja) Ｃ型肝炎ウイルスの陰性化のための投薬システム
Schellekens et al. Oromucosal interferon therapy: relationship between antiviral activity and viral load
JPH04360840A (ja) 血小板減少症治療剤
IMANISHI et al. Elimination of polynucleotide-induced hyporeactivity in mice treated with interferon and antitumor therapy
JPH07103042B2 (ja) ガンマーインターフェロン活性を有するポリペプチドの、初期胸膜癌の治療のための製薬組成物の製造への利用

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE